Kingfisher Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $9.43M | Sell |
10,640
-378
| -3% | -$340K | 2.16% | 8 |
|
|
2024
Q2 | $9.97M | Sell |
11,018
-16
| -0.1% | -$12.8K | 2.33% | 7 |
|
|
2024
Q1 | $8.58M | Sell |
11,034
-21
| -0.2% | -$14.9K | 2.07% | 9 |
|
|
2023
Q4 | $6.44M | Buy |
11,055
+2,440
| +28% | +$1.42M | 1.68% | 13 |
|
|
2023
Q3 | $4.63M | Buy |
8,615
+43
| +0.5% | +$22.2K | 1.26% | 28 |
|
|
2023
Q2 | $4.02M | Sell |
8,572
-637
| -7% | -$267K | 1.05% | 38 |
|
|
2023
Q1 | $3.16M | Buy |
9,209
+6,242
| +210% | +$2.11M | 0.83% | 54 |
|
|
2022
Q4 | $1.09M | Sell |
2,967
-14
| -0.5% | -$4.96K | 0.29% | 91 |
|
|
2022
Q3 | $964K | Hold |
2,981
| – | – | 0.27% | 95 |
|
|
2022
Q2 | $966K | Buy |
2,981
+30
| +1% | +$9.01K | 0.28% | 96 |
|
|
2022
Q1 | $845K | Buy |
2,951
+25
| +0.9% | +$6.43K | 0.22% | 109 |
|
|
2021
Q4 | $808K | Hold |
2,926
| – | – | 0.19% | 120 |
|
|
2021
Q3 | $676K | Buy |
2,926
+100
| +4% | +$24.7K | 0.18% | 121 |
|
|
2021
Q2 | $649K | Sell |
2,826
-255
| -8% | -$51.2K | 0.17% | 127 |
|
|
2021
Q1 | $576K | Buy |
3,081
+226
| +8% | +$44.2K | 0.16% | 131 |
|
|
2020
Q4 | $482K | Buy |
2,855
+55
| +2% | +$8.21K | 0.15% | 132 |
|
|
2020
Q3 | $414K | Hold |
2,800
| – | – | 0.15% | 127 |
|
|
2020
Q2 | $460K | Hold |
2,800
| – | – | 0.2% | 110 |
|
|
2020
Q1 | $388K | Hold |
2,800
| – | – | 0.2% | 115 |
|
|
2019
Q4 | $368K | Hold |
2,800
| – | – | 0.17% | 124 |
|
|
2019
Q3 | $313K | Hold |
2,800
| – | – | 0.19% | 118 |
|
|
2019
Q2 | $310K | Hold |
2,800
| – | – | 0.19% | 107 |
|
|
2019
Q1 | $363K | Hold |
2,800
| – | – | 0.23% | 97 |
|
|
2018
Q4 | $324K | Sell |
2,800
-332
| -11% | -$37.1K | 0.23% | 101 |
|
|
2018
Q3 | $336K | Sell |
3,132
-871
| -22% | -$87.1K | 0.18% | 106 |
|
|
2018
Q2 | $342K | Buy |
4,003
+271
| +7% | +$22.3K | 0.22% | 107 |
|
|
2018
Q1 | $289K | Buy |
3,732
+600
| +19% | +$48.3K | 0.18% | 112 |
|
|
2017
Q4 | $265K | Sell |
3,132
-3
| -0.1% | -$255 | 0.17% | 115 |
|
|
2017
Q3 | $268K | Buy |
3,135
+335
| +12% | +$27.5K | 0.18% | 106 |
|
|
2017
Q2 | $230K | Hold |
2,800
| – | – | 0.16% | 106 |
|
|
2017
Q1 | $236K | Hold |
2,800
| – | – | 0.17% | 103 |
|
|
2016
Q4 | $206K | Hold |
2,800
| – | – | 0.16% | 115 |
|
|
2016
Q3 | $225K | Hold |
2,800
| – | – | 0.16% | 108 |
|
|
2016
Q2 | $221K | Hold |
2,800
| – | – | 0.15% | 113 |
|
|
2016
Q1 | $202K | Hold |
2,800
| – | – | 0.13% | 119 |
|
|
2015
Q4 | $236K | Sell |
2,800
-28
| -1% | -$2.32K | 0.14% | 118 |
|
|
2015
Q3 | $237K | Buy |
2,828
+28
| +1% | +$2.36K | 0.15% | 118 |
|
|
2015
Q2 | $234K | Hold |
2,800
| – | – | 0.13% | 122 |
|
|
2015
Q1 | $203K | Buy |
+2,800
| New | +$199K | 0.11% | 133 |
|
|
2014
Q4 | – | Sell |
-3,300
| Closed | -$214K | – | 146 |
|
|
2014
Q3 | $214K | Buy |
+3,300
| New | +$209K | 0.11% | 135 |
|
Other funds holding LLY
Kingfisher Capital's LLY Position: Q3 2024 in Review
Kingfisher Capital reduced its Eli Lilly (LLY) stake by 3.4% in Q3 2024, selling an estimated $340K and leaving 10,640 shares worth $9.43M. The position accounts for 2.16% of the portfolio, ranked #8.
Kingfisher Capital first reported a position in LLY in Q3 2014 and has held it in 40 quarters since. The position peaked at $9.97M in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.
- Kingfisher Capital held 10,640 shares of Eli Lilly worth $9.43M as of Q3 2024.
- Kingfisher Capital sold 378 Eli Lilly shares in Q3 2024, an estimated $340K.
- Eli Lilly made up 2.16% of Kingfisher Capital's portfolio in Q3 2024, its #8 holding.
- Kingfisher Capital first reported a position in Eli Lilly in Q3 2014 and has held it in 40 quarters since.
- Kingfisher Capital's Eli Lilly position peaked at $9.97M in Q2 2024.
- 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.
Based on Kingfisher Capital's 13F filing for Q3 2024, filed 14 Nov 2024.